![Pragmatic approach to atherosclerotic cardiovascular disease (ASCVD)... | Download Scientific Diagram Pragmatic approach to atherosclerotic cardiovascular disease (ASCVD)... | Download Scientific Diagram](https://www.researchgate.net/publication/333581479/figure/fig1/AS:765764634173440@1559583924027/Pragmatic-approach-to-atherosclerotic-cardiovascular-disease-ASCVD-risk-assessment-and.png)
Pragmatic approach to atherosclerotic cardiovascular disease (ASCVD)... | Download Scientific Diagram
![The Role of GLP-1 RAs in the Management of Type 2 Diabetes and Cardiovascular Risk: Putting it All Together - Part 3 (Monograph) The Role of GLP-1 RAs in the Management of Type 2 Diabetes and Cardiovascular Risk: Putting it All Together - Part 3 (Monograph)](https://www.powerpak.com/courses/119166/fig2.jpg)
The Role of GLP-1 RAs in the Management of Type 2 Diabetes and Cardiovascular Risk: Putting it All Together - Part 3 (Monograph)
Clinical implications of the log linear association between LDL-C lowering and cardiovascular risk reduction: Greatest benefits when LDL-C >100 mg/dl | PLOS ONE
![Frontiers | Clinical Approach to Assessment and Amelioration of Atherosclerotic Vascular Disease in Diabetes Frontiers | Clinical Approach to Assessment and Amelioration of Atherosclerotic Vascular Disease in Diabetes](https://www.frontiersin.org/files/Articles/582826/fcvm-07-582826-HTML/image_m/fcvm-07-582826-t001.jpg)
Frontiers | Clinical Approach to Assessment and Amelioration of Atherosclerotic Vascular Disease in Diabetes
![Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog](https://blog.endokrinologie.net/wp-content/uploads/2018/11/ADA-EASD-Guidelines-2018-2.jpg)
Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog
Aspirin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease: Summarizing Current Evidence
![Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus | Journal of the American Heart Association Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/b56d6f9e-a93c-415f-8426-d40be6831caa/jah36377-fig-0001.png)
Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus | Journal of the American Heart Association
![The four statin-benefit groups. ASCVD atherosclerotic cardiovascular... | Download Scientific Diagram The four statin-benefit groups. ASCVD atherosclerotic cardiovascular... | Download Scientific Diagram](https://www.researchgate.net/publication/291689960/figure/fig2/AS:962676435976214@1606531356844/The-four-statin-benefit-groups-ASCVD-atherosclerotic-cardiovascular-disease-CV.gif)
The four statin-benefit groups. ASCVD atherosclerotic cardiovascular... | Download Scientific Diagram
![Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol | Cardiovascular Diabetology | Full Text Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-020-0991-1/MediaObjects/12933_2020_991_Fig1_HTML.png)
Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol | Cardiovascular Diabetology | Full Text
![Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus - ScienceDirect Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914918311834-gr1.jpg)
Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus - ScienceDirect
![Recent Tendency of Nutritional Standard for Diabetes Mellitus with Chronic Kidney Disease (CKD) and Arteriosclerotic Cardiovascular Recent Tendency of Nutritional Standard for Diabetes Mellitus with Chronic Kidney Disease (CKD) and Arteriosclerotic Cardiovascular](https://i0.wp.com/asploro.com/wp-content/uploads/2021/12/Fig-1_Recent-Tendency-of-Nutritional-Standard-for-Diabetes-Mellitus.jpg?ssl=1)